Gene targeting in kidney development

Medical and Pediatric Oncology

Volumn 27, Issue 5, 1996, Pages 445-452

  Kreidberg, Jordan A ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

gene knockout; gene targeting; kidney development; Wilms' tumor

Indexed keywords

ONCOPROTEIN; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR RECEPTOR; TRANSCRIPTION FACTOR;

ANIMAL MODEL; ARTICLE; GENE MUTATION; GENE TARGETING; KIDNEY DEVELOPMENT; KIDNEY MALFORMATION; KIDNEY POLYCYSTIC DISEASE; LIMB DEFORMITY; MESENCHYME CELL; MOUSE; NEPHROBLASTOMA; NONHUMAN; ONCOGENE; ONCOGENE C MYB; PRIORITY JOURNAL; STEM CELL; TRANSGENIC MOUSE;

ANIMALS; DNA-BINDING PROTEINS; DROSOPHILA PROTEINS; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE TARGETING; GENES, WILMS TUMOR; HOMEODOMAIN PROTEINS; KIDNEY; KIDNEY NEOPLASMS; MICE; MICE, MUTANT STRAINS; MICE, TRANSGENIC; ONCOGENES; PHENOTYPE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; TRANSCRIPTION FACTORS; UROGENITAL SYSTEM; WILMS TUMOR; WNT PROTEINS; WT1 PROTEINS;

EID: 0029818609     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(199611)27:5<445::AID-MPO10>3.0.CO;2-9     Document Type: Article

References (76)

1. Bradley A, Robertson E: Embryo-derived stem cells: A tool for elucidating the developmental genetics of the mouse. Curr Top Dev Biol 20:357-371, 1986.
2. Capecchi MR: The new mouse genetics: Altering the genome by gene targeting. Trends Genet 5:70-76, 1989.
3. Doetschman TC, Eistetter H, Katz M, Schmidt W, Kemler R: The in vitro development of blastocyst-derived embryonic stem cell lines: Formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morphol 87:27-45, 1985.
4. Robertson EJ: Isolation of embryonic stem cells. In Robertson EJ (ed): "Teratocarcinomas and Embryonic Stem Cells: A Practical Approach." Oxford: IRL Press, 71-112, 1987.
5. Robertson E, Bradley A, Kuehn M, Evans M: Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vector. Nature 323:445-448, 1986.
6. Doetschman T, Gossler A, Serfling E, Schaffner W, Marcu K, Stanton L, Kemler R: Introduction of genes into mouse embryonic stem cells. Prog Clin Biol Res 1:47-50, 1986.
7. Bradley A: Production and analysis of chimeric mice. In Robertson EJ (ed): "Teratocarcinomas and Embryonic Stem Cells: A Practical Approach." Oxford: IRL Press, 1987, pp. 113-151.
8. Saxen L: Organogenesis of the Kidney. Cambridge: Cambridge University Press, 1987.
9. Grobstein C: Inductive interactions in the development of the mouse metanephros. J Exp Zool 130:319-340, 1955.
10. Grobstein C: Inductive epithelio-mesenchymal interaction in the cultured organ rudiments of the mouse. Science 118:52-55, 1953.
11. Saxen L, Lehtonen E, Karkinen-Jaaskelainen M, Nordling S, Wartiovaara J: Are morphogenetic tissue interactions mediated by transmissible signal substances or through cell contacts? Nature 259:662-663, 1976.
12. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH, et al.: Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60:509-520, 1990.
13. Dey BR, Sukhatme VP, Roberts AB, Sporn MB, Rauscher FR, Kim SJ: Repression of the transforming growth factor-beta 1 gene by the Wilms' tumor suppressor WT1 gene product. Mol Endocrin 8:595-602, 1994.
14. Drummond IA, Madden SL, Rohwer-Nutter P, Bell GI, Sukhatme VP, Rauscher FD: Repression of the insulin-like growth factor II gene by the Wilms' tumor suppressor WT1. Science 257:674-678, 1992.
15. Madden SL, Cook DM, Morris JF, Gashler A, Sukhatme VP, Rauscher F: Transcriptional repression mediated by the WT1 Wilms' tumor gene product. Science 253:1550-1553, 1991.
16. Rauscher FD, Morris JF, Tournay OE, Cook DM, Curran T: Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence. Science 250:1259-1262, 1990.
17. Gashler AL, Bonthron DT, Madden SL, Rauscher FD, Collins T, Sukhatme VP: Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms' tumor suppressor WT1. Proc Natl Acad Sci USA 89:10984-10988, 1992.
18. Wang ZY, Madden SL, Deuel TF, Rauscher FD: The Wilms' tumor gene product, WT1, represses transcription of the platelet-derived growth factor A-chain gene. J Biol Chem 267:21999-22002, 1992.
19. Pelletier JW, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Streigel JE, Houghton DC, Junien C, Habib R, Fouser L, et al.: Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 67:437-447, 1991.
20. Hastie ND: The genetics of Wilms' tumor- A case of disrupted development. Annu Rev Genet 28:523-558, 1994.
21. Denys P, Malvaux P, Van Den Berghe H, Tanghe W, Proesmans W: Association of an anatomo-pathological syndrome of male pseudohermaphroditism, Wilms' tumor, parenchymatous nephropathy and XX/XY mosaicism. Arch Fr Pediatr 24:729-739, 1967.
22. Drash A, Sherman F, Hartmann WH, Blizzard RM: A syndrome of pseudohermaphroditism, Wilms' tumor, hypertension, and degenerative renal disease. J Pediatr 76:585-593, 1970.
23. Habib R, Loirat C, Gubler MC, Niaudet P, Bensman A, Levy M, Broyer M: The nephropathy associated with male pseudohermaphroditism and Wilms' tumor (Drash syndrome): A distinctive glomerular lesion - Report of 10 cases. Can Nephrol 24:269-278, 1985.
24. Pelletier J, Bruening W, Li FP, Haber DA, Glaser T, Housman DE: WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour. Nature 353:431-434, 1991.
25. Little MH, Williamson KA, Mannens M, Kelsey A, Gosden C, Hastie ND, van Heyningen V: Evidence that WT1 mutations in Denys-Drash syndrome patients may act in a dominant-negative fashion. Hum Mol Genet 2:259-264, 1993.
26. Coppes MJ, Huff V, Pelletier J: Denys-Drash syndrome: Relating a clinical disorder to genetic alterations in the tumor suppressor gene WT1. J Pediatr 123:673-678, 1993.
27. Bruening W, Bardeesy N, Silverman BL, Cohn RA, Machin GA, Aronson AJ, Housman D, Pelletier J: Germline intronic and exonic mutations in the Wilms' tumour gene (WT1) affecting urogenital development. Nature Genet 1:144-148, 1992.
28. Knudson AG Jr, Strong LC: Mutation and cancer A model for Wilms' tumor of the kidney. J Natl Cancer Inst 48:313-324, 1972.
29. Haber DA, Housman DE: The genetics of Wilms' tumor. Adv Cancer Res 59:41-68, 1992.
30. Beckwith JB, Kiviat NB, Bonadio JF: Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor. Pediatr Pathol 10:1-36, 1990.
31. Heppe RK, Koyle MA, Beckwith JB: Nephrogenic rests in Wilms' tumor patients with the Drash syndrome. J Urol 145:1225-1228, 1991.
32. Park S, Bernard A, Bove KE, Sens DA, Hazen-Martin DJ, Garvin AJ, Haber DA: Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour. Nature Genet 5:363-367, 1993.
33. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, Jaenisch R: WT1 is required for early kidney development. Cell 74:679-691, 1993.
34. Stark K, Vainio S, Vassileva G, McMahon AP: Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4. Nature 372:679-683, 1994.
35. Avantaggiato V, Dathan NA, Grieco M, Fabien N, Lazzaro D, Fusco A, Simeone A, Santoro M: Developmental expression of the RET protooncogene. Cell Growth Differ 5:305-311, 1994.
36. Schuchardt A, D'Agati V, Larsson BL, Constantini F, Pachnis V: Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. [see comments]. Nature 367:380-383, 1994.
37. Tessarollo L, Nagarajan L, Parada LF: c-ros: The venebrate homolog of the sevenless tyrosine kinase receptor is tightly regulated during organogenesis in mouse embryonic development. Development 115:11-20, 1992.
38. Woychik RP, Stewart TA, Davis LG, D'Eustachio P, Leder P: An inherited limb deformity created by insertional mutagenesis in a transgenic mouse. Nature 318:36-40, 1985.
39. Maas R, Elfering S, Glaser T, Jepeal L: Deficient outgrowth of the ureteric bud underlies the renal agenesis phenotype in mice manifesting the limb deformity (1d) mutation. Dev Dynamics 199:214-228, 1994.
40. Vogt TF, Jackson GL, Rush J, Leder P: Formins: Phosphoprotein isoforms encoded by the mouse limb deformity locus. Proc Natl Acad Sci USA 90:5554-5558, 1993.
41. Leveen P, Pekny M, Gebre MS, Swolin B, Larsson E, Betsholtz C: Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev 8:1875-1887, 1994.
42. Soriano P: Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Genes Dev 8:1888-1896, 1994.
43. Shultz PJ, DiCorleto PE, Silver BJ, Abboud HE: Mesangial cells express PDGF mRNAs and proliferate in response to PDGF. Am J Physiol 255:F674-F684, 1988.
44. Charron J, Malynn BA, Fisher P, Stewart V, Jeannotte L, Goff SP, Robertson EJ, Alt FW: Embryonic lethality in mice homozygous for a targeted disruption of the N-myc gene. Genes Dev 6:2248-2257, 1992.
45. Davis AC, Wims M, Spotts GD, Hann SR, Bradley A: A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes Dev 7:671-782, 1993.
46. Sawai S, Shimono A, Wakamatsu Y, Palmes C, Hanaoka K, Kondoh H: Defects of embryonic organogenesis resulting from targeted disruption of the N-myc gene in the mouse. Development, 117: 1445-1455, 1993.
47. Stanton BR, Perkins AS, Tessarollo L, Sassoon DA, Parada LF: Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop. Genes Dev 6:2235-2247, 1992
48. Mugrauer G, Alt FW, Ekblom P: N-myc proto-oncogene expression during organogenesis in the developing mouse as revealed by in situ hybridization. J Cell Biol 107:1325-1335, 1988.
49. Mugrauer G, Ekblom P: Contrasting expression patterns of three members of the myc family of protooncogenes in the developing and adult mouse kidney. J Cell Biol 112:13-25, 1991.
50. Shawlot W, Behringer RR: Requirement for Lim1 in head-organizer function. Nature 374:425-430, 1995.
51. Fujii T, Pichel JG, Taira M, Toyama R, Dawid IB, Westphal H: Expression patterns of the murine LIM class homeobox gene lim1 in the developing brain and excretory system. Dev Dynamics 199:73-83, 1994.
52. Dressier GR, Wilkinson JE, Rothenpieler UW, Patterson LT, Williams SL and H Westphal. Deregulation of Pax-2 expression in transgenic mice generates severe kidney abnormalities. Nature 362:65-67, 1993.
53. Ryan G, Steele-Perkins V, Morris JF, Rauscher FJL, Dressler GR: Repression of Pax-2 by WT-1 during normal kidney development. Development 121:867-875, 1995.
54. Dressier GR, Douglass EC: Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms' tumor. Proc Natl Acad Sci USA 89:1179-1183, 1992.
55. Dressler GR, Deutsch U, Chowdhury K, Nornes HO, Gruss P: Pax2, a new murine paired-box-containing gene and its expression in the developing excretory system. Development 109:787-795, 1990.
56. Glueckson-Schonheimer S: The morphological manifestations of a dominant mutation in mice affecting the urogenital system. Genetics 28:341-348, 1943.
57. Mesrobian HG, Sulik KK: Characterization of the upper urinary tract anatomy in the Danforth spontaneous murine mutation. J Urol 148:752-755, 1992.
58. Nakayama K, Nakayama K, Negishi I, Kuida K, Sawa H, Loh DY: Targeted disruption of Bcl-2 alpha beta in mice: Occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. Proc Natl Acad Sci USA 91:3700-3704, 1994.
59. Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ: Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75:229-240, 1993.
60. Moyer JH, Lee TM, Kwon HY, Schrick JJ, Avner ED, Sweeney WE, Godfrey VL, Cacheiro NL, Wilkinson JE, Woychik RP: Candidate gene associated with a mutation causing recessive polycystic kidney disease in mice. Science 264:1329-1333, 1994.
61. Masunaga H, Hirabayashi M, Takahira R, Imai E, Kawanishi G: Renal anemia in polycystic kidney disease mouse. J Vet Med Sci 53:621-627, 1991.
62. Nauta J, Ozawa Y, Sweeney WJ, Rutledge JC, Avner ED: Renal and biliary abnormalities in a new murine model of autosomal recessive polycystic kidney disease. Pediatr Nephrol 7:163-172, 1993.
63. Atala A, Freeman MR, Mandell J, Beier DR: Juvenile cystic kidneys (jck): A new mouse mutation which causes polycystic kidneys. Kidney Int 43:1081-1085, 1993.
64. Simon EA, Cook S, Davisson MT, D'Eustachio P, Guay WL: The mouse congenital polycystic kidney (cpk) locus maps within 1.3 cM of the chromosome 12 marker D12Nyu2. Genomics 21:415-418, 1994.
65. Calvet JP: Polycystic kidney disease: Primary extracellular matrix abnormality or defective cellular differentiation? [Review]. Kidney Int 43:101-108, 1993.
66. Rogers SA, Ryan G, Hammerman MR: Metanephric transforming growth factor-alpha is required for renal organogenesis in vitro. Am J Physiol 262:F533-F539, 1992.
67. Rogers SA, Ryan G, Purchio AF, Hammerman MR: Metanephric transforming growth factor-beta 1 regulates nephrogenesis in vitro. Am J Physiol 264:F996-F1002, 1993.
68. Baker J, Liu JP, Robertson EJ, Efstratiadis A: Role of insulin-like growth factors in embryonic and postnatal growth. Cell 73-82, 1993.
69. Luetteke NC, Qiu TH, Peiffer RL, Oliver P, Smithies O, Lee DC: TGF alpha deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice. Cell 73:263-278, 1993.
70. Mann GB, Fowler KJ, Gabriel A, Nice EC, Williams RL, Dunn AJR: Mice with a null mutation of the TGF alpha gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation. Cell 73:249-261, 1993.
71. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A: Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59-72, 1993.
72. DeChiara TM, Robertson EJ, Efstratiadis A: Parental imprinting of the mouse insulin-like growth factor II gene. Cell 64:849-859, 1991.
73. Dudley AT, Lyons KM, and Robertson EJ: A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye, Genes & Development, 9(22): p. 2795-807, 1995.
74. Luo G, Hofmann C, Bronckers AL, Sohocki M, Bradley A, and Karsenty G: BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning, Genes & Development, 9(22): p. 2808-20, 1995.
75. Torres M, Gornez PE, Dressier GR, and Gruss P: Pax-2 controls multiple steps of urogenital development, Development, 121(12): p. 4057-65, 1995.
76. Hatani V, Huh SO, Herzlinger D, Soares VC, and Lai E: Essential role of stromal mesenchyme in kidney morphogenesis revealed by targeted disruption of winged helix transcription factor BF-2, Genes and Development, 10: p. 1467-1478, 1996.